Haroun Gajraj/LinkedIn
Nov 15, 2025, 15:42
Haroun Gajraj Thanks Enric Roche for Demonstrating the Piston Effect
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, reposted from Enric Roche, on LinkedIn:
“Thank you, Enric Roche, MD, PhD, for a very nice demonstration of the piston effect in foam sclerotherapy.”
Quoting Enric Roche’s post:
“This is what we call the piston effect in foam sclerotherapy. The foam uniformly displaces the blood, maintaining its structure and promoting contact between the sclerosant and the endothelium. To optimise this effect in all concentrations and drugs is always an advantage to get better outcomes. This behaviour occurs with dry foams due to their greater stability.
This is a 0.2% Polidocanol foam.”
Stay informed with Hemostasis Today.
-
Jul 8, 2026, 14:17Maha Othman: Advancing Thrombosis and Hemostasis Research at ISTH 2026
-
Jul 8, 2026, 14:07Zain Khalpey: Atrial Fibrillation as the Hidden Driver of Preventable Ischemic Stroke
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis